Literature DB >> 32124417

Intraoperative Margin Assessment in Head and Neck Cancer: A Case of Misuse and Abuse?

Mark W Kubik1, Shaum Sridharan1, Mark A Varvares2, Dan P Zandberg3, Heath D Skinner4, Raja R Seethala5, Simion I Chiosea6.   

Abstract

Surgical removal with negative margins is the preferred management of oral squamous cell carcinomas. This review summarizes statements by professional organizations and data supporting the specimen-driven approach to margin assessment. Practical aspects of the intraoperative margin assessment, as guided by gross examination, are presented. The most cost- and time-efficient method of intraoperative margin assessment depends on desired margin clearance and likelihood of other adverse histologic factors, such as extranodal extension, perineural invasion, which are likelier in advanced carcinomas. Intraoperative surgeon-pathologist communication can be improved by reporting to surgical team gross distances to all or selected closest margins, before choosing margins for microscopic frozen examination. Case specific mitigation strategies to minimize the negative impact of tumor-bed driven margin assessment or of suboptimal margin revision are proposed. Based on size, shape, histology, size of carcinoma at the margin, and orientation of the additional tissue, margin revision may be judged as adequate (conversion of a positive margin into a negative one), inadequate (positive margin remains positive), or indeterminate. The significance of anatomic subsite based labeling, radial margin sampling from the main resection specimen, and the relationship between the distance to closest margin and local control are highlighted. The modern definition of safe margin would account for other parameters, such as perineural invasion. An updated approach to resolution of frozen versus permanent sampling issues is outlined. Future studies are needed to design and validate risk models that would help to determine for individual patient what represents a safe margin and how to judge the quality of margin revision.

Entities:  

Keywords:  Frozen; Gross examination; Margin; Oral cavity; Squamous cell carcinoma

Mesh:

Year:  2020        PMID: 32124417      PMCID: PMC7235105          DOI: 10.1007/s12105-019-01121-2

Source DB:  PubMed          Journal:  Head Neck Pathol        ISSN: 1936-055X


  32 in total

1.  Early squamous cell carcinoma of the oral tongue: comparing margins obtained from the glossectomy specimen to margins from the tumor bed.

Authors:  Ann Margaret V Chang; Seungwon W Kim; Umamaheswar Duvvuri; Jonas T Johnson; Eugene N Myers; Robert L Ferris; William E Gooding; Raja R Seethala; Simion I Chiosea
Journal:  Oral Oncol       Date:  2013-08-27       Impact factor: 5.337

Review 2.  A meta-analysis of margin size and local recurrence in oral squamous cell carcinoma.

Authors:  Caroline Rachael Anderson; Katherine Sisson; Marc Moncrieff
Journal:  Oral Oncol       Date:  2015-02-21       Impact factor: 5.337

Review 3.  Intraoperative Margin Assessment in Early Oral Squamous Cell Carcinoma.

Authors:  Simion I Chiosea
Journal:  Surg Pathol Clin       Date:  2016-12-10

4.  Patients with revised surgical resection margins are best studied as a distinct group.

Authors:  Steven M Sperry; Mark A Varvares; Simion I Chiosea
Journal:  Cancer       Date:  2018-10-09       Impact factor: 6.860

5.  Margin assessment in oral squamous cell carcinoma.

Authors:  Uma Duvvuri; Raja R Seethala; Simion Chiosea
Journal:  Cancer       Date:  2013-11-05       Impact factor: 6.860

6.  Standardized Margin Assessment Is Needed Before Implementing Negative Margin as a Quality Measure.

Authors:  Umamaheswar Duvvuri; Jonas T Johnson; Simion I Chiosea
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2018-06-01       Impact factor: 6.223

7.  Analysis of risk factors of predictive local tumor control in oral cavity cancer.

Authors:  Chun-Ta Liao; Joseph Tung-Chieh Chang; Hung-Ming Wang; Shu-Hang Ng; Chuen Hsueh; Li-Yu Lee; Chih-Hung Lin; I-How Chen; Shiang-Fu Huang; Ann-Joy Cheng; Tzu-Chen Yen
Journal:  Ann Surg Oncol       Date:  2007-12-29       Impact factor: 5.344

8.  Early Oral Tongue Squamous Cell Carcinoma: Sampling of Margins From Tumor Bed and Worse Local Control.

Authors:  Jessica H Maxwell; Lester D R Thompson; Margaret S Brandwein-Gensler; Bernhard G Weiss; Martin Canis; Bibianna Purgina; Arpan V Prabhu; Chi Lai; Yongli Shuai; William R Carroll; Anthony Morlandt; Umamaheswar Duvvuri; Seungwon Kim; Jonas T Johnson; Robert L Ferris; Raja Seethala; Simion I Chiosea
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2015-12       Impact factor: 6.223

9.  Does adjuvant radiation therapy improve outcomes in pT1-3N0 oral cavity cancer with tumor-free margins and perineural invasion?

Authors:  Chun-Ta Liao; Joseph Tung-Chieh Chang; Hung-Ming Wang; Shu-Hang Ng; Chuen Hsueh; Li-Yu Lee; Chih-Hung Lin; I-How Chen; Shiang-Fu Huang; Ann-Joy Cheng; Lai-Chu See; Tzu-Chen Yen
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-06-01       Impact factor: 7.038

10.  Association of Main Specimen and Tumor Bed Margin Status With Local Recurrence and Survival in Oral Cancer Surgery.

Authors:  Marisa R Buchakjian; Kendall K Tasche; Robert A Robinson; Nitin A Pagedar; Steven M Sperry
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2016-12-01       Impact factor: 6.223

View more
  7 in total

1.  Association of Intraoperative Frozen Section Controls With Improved Margin Assessment During Transoral Robotic Surgery for Human Papillomavirus-Positive Oropharyngeal Squamous Cell Carcinoma.

Authors:  Alice C Yu; David D Afework; Jeffrey D Goldstein; Elliot Abemayor; Abie H Mendelsohn
Journal:  JAMA Otolaryngol Head Neck Surg       Date:  2022-09-22       Impact factor: 8.961

2.  Fluorescent Molecular Imaging Can Improve Intraoperative Sentinel Margin Detection in Oral Squamous Cell Carcinoma.

Authors:  Giri Krishnan; Nynke S van den Berg; Naoki Nishio; Shrey Kapoor; Jaqueline Pei; Laura Freeman; Yu-Jin Lee; Quan Zhou; Stan van Keulen; Shayan Farkurnejad; James Condon; Fred M Baik; Brock A Martin; Eben L Rosenthal
Journal:  J Nucl Med       Date:  2022-01-13       Impact factor: 11.082

Review 3.  Frozen-Permanent Section Discrepancy Rate in Oral Cavity and Oropharyngeal Squamous Cell Carcinoma.

Authors:  Serenella Serinelli; Stephanie M Bryant; Michael P A Williams; Mark Marzouk; Daniel J Zaccarini
Journal:  Head Neck Pathol       Date:  2021-10-16

4.  LKB-1 Expression and High-Risk Histopathology are Independent Prognostic Factors for Patients with Oral Cavity Carcinoma.

Authors:  José F Carrillo; Christian Cruz-Romero; Alejandro Avilés-Salas; Liliana C Carrillo; Margarita C Ramírez-Ortega; Roberto Herrera-Goepfert; Rafael Vázquez-Romo; Gabriela Figueroa-González; Javier I Altamirano-García; Luis F Oñate-Ocaña
Journal:  Ann Surg Oncol       Date:  2022-03-23       Impact factor: 5.344

5.  Systematic interpretation of confocal laser endomicroscopy: larynx and pharynx confocal imaging score.

Authors:  Matti Sievert; Konstantinos Mantsopoulos; Sarina K Mueller; Markus Eckstein; Robin Rupp; Marc Aubreville; Florian Stelzle; Nicolai Oetter; Andreas Maier; Heinrich Iro; Miguel Goncalves
Journal:  Acta Otorhinolaryngol Ital       Date:  2022-02-07       Impact factor: 2.618

6.  Validity of tissue homogeneity in confocal laser endomicroscopy on the diagnosis of laryngeal and hypopharyngeal squamous cell carcinoma.

Authors:  Matti Sievert; Marc Aubreville; Antoniu-Oreste Gostian; Konstantinos Mantsopoulos; Michael Koch; Sarina Katrin Mueller; Markus Eckstein; Robin Rupp; Florian Stelzle; Nicolai Oetter; Andreas Maier; Heinrich Iro; Miguel Goncalves
Journal:  Eur Arch Otorhinolaryngol       Date:  2022-02-28       Impact factor: 3.236

7.  Influence of Case Management Model Combined with Continuous Nursing Care on Compliance Behavior and Adverse Emotions in Elderly Patients with Lung Cancer: A Prospective Single-Center Case-Control Study.

Authors:  Aomei Li; Jie Gao; Juan Ni; Yuxin Che; Qing Zhang; Qian Hu; Jie Pan; YuXin Ge; Zhenzhu Cao; Juan Ni
Journal:  Comput Math Methods Med       Date:  2022-08-24       Impact factor: 2.809

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.